An interview with Andrew MacGarvey, who has been involved in the clinical research enterprise for more 25 years and is now CEO and Founder of Coronado Research, which recently launched in the United Kingdom as a consultancy-led, professional services organization operating in the clinical development arena.
The integration of digital tools has brought better efficiency to clinical trials. Among these innovations, wearable devices are changing how data are collected, monitored, and analyzed. The use of wearables also changes how study teams interact with their participants.
This is a sponsored message.
The clinical research industry plays a vital role in advancing medical knowledge and improving healthcare; however, the increasing complexity of clinical trials has created […]
Just when it seemed as if decentralized clinical trials (DCTs) were in danger of becoming “yesterday’s news” in light of all the attention being paid lately to applications of artificial intelligence in the clinical research enterprise, the tables have turned, if perhaps only briefly, thanks to the release of finalized new U.S. Food and Drug Administration (FDA) regulatory guidance on DCTs.
The increased accessibility of generative artificial intelligence (Gen AI) models like OpenAI’s ChatGPT and DALL-E has captured the popular imagination. You’d be hard-pressed now to find any leadership team in any sector that isn’t at least considering ways to leverage Gen AI.